Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. - Wikidata - awgldk - TriplyDB

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

http://www.wikidata.org/entity/Q34030056

about

Serotonin syndrome: a brief review Depression and Exercise: A Clinical Review and Management Guideline Psychiatric services in primary care settings: a survey of general practitioners in Thailand.Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).Modulating Oxidative Stress Relieves Stress-Induced Behavioral and Cognitive Impairments in Rats.A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy Tolerability and safety of fluvoxamine and other antidepressants.Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event Diagnosis and management of depression in primary care: a clinical update and review.Investigational drugs in recent clinical trials for treatment-resistant depression.Toward achieving optimal response: understanding and managing antidepressant side effects Depression sum-scores don't add up: why analyzing specific depression symptoms is essential The mechanisms by which antidepressants may reduce coronary heart disease risk Antidepressant prescribing in Irish children: secular trends and international comparison in the context of a safety warning.Emergent anxiety after antidepressant initiation: a retrospective cohort study of Veterans Affairs Health System patients with depression.Risk factors for ileus in patients with schizophrenia.Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression Quality of life and use of health care resources among patients with chronic depression Panic disorder and serotonin reuptake inhibitors predict coupling of cortical and cardiac activity.Diagnosis and management of xerostomia and hyposalivation.Effects of psychological stress and fluoxetine on development of oral candidiasis in rats Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.

P2860

Q24678431-5D314C12-1CE5-4026-BF95-AFC9955FE695 Q26785999-816FC755-1333-4D9F-9F9D-D4F09E0D5877 Q33251728-1CD6264C-3D43-4872-B8FC-8A58949C5CBB Q33458842-026EE904-0E92-49A8-9350-A6BB63476C80 Q33635906-D00F9F37-4433-4755-9A7A-52EAD7761C7B Q33858253-9253972E-05C8-4DB0-BB19-2A92A33B6436 Q33884174-55203CC9-D8A0-483C-80B0-E2E563AE0883 Q33995120-00A30D8F-B707-47C6-85A5-F6AD9193E47E Q34140313-815594CE-DA1F-456E-A628-6BA09FD80418 Q34254787-87F13BDF-E51F-485F-A07D-5D9528983E80 Q34288455-BDEFA9D0-DBA3-488E-BD03-D9B1CB1F09BF Q34549390-7157F3F9-ACF2-42C3-9ADC-30556F34105B Q35237051-9978A874-3CF6-4D3A-99D7-97B9A088CC07 Q35276531-C96A1DD0-BE37-407C-9DFC-2EF2814D1476 Q35731801-4CFEF50C-9275-47C8-AF87-7BC490FAD577 Q35771405-75E1348E-275E-4612-90DC-8582A4C39CD5 Q35841410-85F6A500-F384-4F45-A13A-B0B249F761FE Q35898751-B086149C-5328-4B66-9E1A-3B69FA575353 Q36020033-0250716C-BE58-4650-9E2B-7601B0EECEEA Q37271283-26387218-68A5-4D6C-8C18-38CF546CFE1C Q37301359-9A5FE86B-93AB-49E1-95EB-1CF1CB284BC3 Q37409607-FAAEF630-F1BD-4A16-B282-CACD8FB62789 Q38344791-DB600455-70D5-45AA-8320-7D1DF4C2F8B7 Q39894180-7A647047-0DB5-45C9-9C3D-34B72CCE431F Q40810950-57835FE4-EE16-464F-82BD-92AAD21B35EB Q52686485-A6F0860C-3122-49AC-BD7E-B8D6B034DC6C

P2860

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

http://www.wikidata.org/entity/Q34030056

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Adverse effects associated wit ...... idepressants: a meta-analysis.

@ast

Adverse effects associated wit ...... idepressants: a meta-analysis.

@en

Adverse effects associated wit ...... idepressants: a meta-analysis.

@nl

type

label

Adverse effects associated wit ...... idepressants: a meta-analysis.

@ast

Adverse effects associated wit ...... idepressants: a meta-analysis.

@en

Adverse effects associated wit ...... idepressants: a meta-analysis.

@nl

prefLabel

Adverse effects associated wit ...... idepressants: a meta-analysis.

@ast

Adverse effects associated wit ...... idepressants: a meta-analysis.

@en

Adverse effects associated wit ...... idepressants: a meta-analysis.

@nl

P1433

Q34030056-182287D7-FA4F-4319-8E5A-03117639433E

P1476

Q34030056-212E332D-1AB3-4CAE-8155-A6DF2CBF42F1

P2093

Q34030056-4A374141-B642-48A7-9BE7-573CC50147C4

Q34030056-BFB58F11-62CE-4540-A3CB-4A43F403E5B1

Q34030056-C8D8E41F-E0F3-4E98-AF01-B340CA7B5A57

Q34030056-EBDA103C-E0AC-461B-B907-0D8CBCF8989B

P2860

Q34030056-02D6FFD5-0A43-4FEC-9970-AE30BF5FC672

Q34030056-07DB1EAE-667D-46C7-A33B-35F00FBA99B2

Q34030056-0A6DE50E-63F6-4A4E-9495-F1B14D596E77

Q34030056-0FF980A4-2872-46F6-BEAC-ABADB35192F6

Q34030056-148CAD82-3648-4CFC-BF60-4601E72DD73F

Q34030056-198DE67B-EA17-4A24-A105-0E9C7DC74DE8

Q34030056-1C133DC4-A5BE-4624-BC39-60E415DEDAAF

Q34030056-1F5DC66B-F507-4435-A591-23611BD4C8CA

Q34030056-2452DFAB-2D1C-48BB-9778-1BE8B2DB32E8

Q34030056-2828E3F1-E744-418A-A025-162D5D530116

P304

Q34030056-148C404C-6434-4DF1-BA5E-D7B40D379F1C

P31

Q34030056-17445cf3-20f0-41b2-bfd1-179b7aa0f5bd

Q34030056-2D9E1672-796F-4693-B210-B6FFE1E18998

P407

Q34030056-B29D65EC-50E2-48F3-AF49-EF4DAEB0AC61

P433

Q34030056-094AE5CD-96FB-443A-9C0B-96295D53CC45

P478

Q34030056-027B7C6F-F4E4-4D2F-87C2-272371D77E16

P577

Q34030056-53C99445-F9C6-421D-95B3-EA5213833852

P698

Q34030056-5B9EF698-B3E4-4DD2-A7F8-D023528D9CD0

P921

Q34030056-936FC325-F0EE-4168-9043-F8CE797A2841

Q34030056-994fddc5-0c8c-4f07-b498-4c8ffd292a49

P932

Q34030056-5B02A1DC-AA58-4780-AF79-8B396B44869D

P1433

Canadian Medical Association Journal

P1476

Adverse effects associated wit ...... idepressants: a meta-analysis.

@en

P2093

Coloma C

http://www.w3.org/2001/XMLSchema#string

Menon D

http://www.w3.org/2001/XMLSchema#string

Topfer LA

http://www.w3.org/2001/XMLSchema#string

Trindade E

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression

The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.

Antidepressant drugs and the emergence of suicidal tendencies.

Are SSRIs a cost-effective alternative to tricyclics?

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

Treatment of major depression in general practice: a double-blind comparison of paroxetine and lofepramine.

Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

P304

1245-1252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

159

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9861221

http://www.w3.org/2001/XMLSchema#string

P921

P932

1229819

http://www.w3.org/2001/XMLSchema#string